317 related articles for article (PubMed ID: 7898661)
21. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model.
Nikkhah G; Bentlage C; Cunningham MG; Björklund A
J Neurosci; 1994 Jun; 14(6):3449-61. PubMed ID: 7911516
[TBL] [Abstract][Full Text] [Related]
22. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
23. Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts.
Smits A; Odin P; Duan WM; Brundin P; Widner H; Heldin CH; Lindvall O; Funa K
Cell Transplant; 1993; 2(2):151-62. PubMed ID: 7908247
[TBL] [Abstract][Full Text] [Related]
24. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood.
Abrous DN; Torres EM; Dunnett SB
Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254
[TBL] [Abstract][Full Text] [Related]
25. Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys.
Elsworth JD; Sladek JR; Taylor JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 1996 May; 72(2):477-84. PubMed ID: 8737417
[TBL] [Abstract][Full Text] [Related]
26. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
[TBL] [Abstract][Full Text] [Related]
27. Development of intrastriatal striatal grafts and their afferent innervation from the host.
Labandeira-Garcia JL; Wictorin K; Cunningham ET; Björklund A
Neuroscience; 1991; 42(2):407-26. PubMed ID: 1716746
[TBL] [Abstract][Full Text] [Related]
28. Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences.
Abrous N; Guy J; Vigny A; Calas A; Le Moal M; Herman JP
J Comp Neurol; 1988 Jul; 273(1):26-41. PubMed ID: 3145292
[TBL] [Abstract][Full Text] [Related]
29. Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants.
Zhou J; Bradford HF; Stern GM
Brain Res Dev Brain Res; 1997 May; 100(1):43-51. PubMed ID: 9174245
[TBL] [Abstract][Full Text] [Related]
30. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
Espejo M; Cutillas B; Arenas TE; Ambrosio S
Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
[TBL] [Abstract][Full Text] [Related]
31. Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts.
Strömberg I; Johansson M
Exp Brain Res; 1994; 101(1):73-85. PubMed ID: 7843304
[TBL] [Abstract][Full Text] [Related]
32. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon.
Johansson S; Strömberg I
J Comp Neurol; 2002 Feb; 443(3):237-49. PubMed ID: 11807834
[TBL] [Abstract][Full Text] [Related]
33. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
Bartlett LE; Mendez I
Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
[TBL] [Abstract][Full Text] [Related]
34. Astrogliosis has Different Dynamics after Cell Transplantation and Mechanical Impact in the Rodent Model of Parkinson's Disease.
Tomov N; Surchev L; Wiedenmann C; Döbrössy MD; Nikkhah G
Balkan Med J; 2018 Mar; 35(2):141-147. PubMed ID: 29039346
[TBL] [Abstract][Full Text] [Related]
35. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.
Barker RA; Dunnett SB; Faissner A; Fawcett JW
Exp Neurol; 1996 Sep; 141(1):79-93. PubMed ID: 8797670
[TBL] [Abstract][Full Text] [Related]
36. Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease.
Sommer C; Sabel M; Oertel WH; Kiessling M; Sautter J
Brain Res Mol Brain Res; 1999 May; 69(1):53-61. PubMed ID: 10350637
[TBL] [Abstract][Full Text] [Related]
37. Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase.
Barkats M; Nakao N; Grasbon-Frodl EM; Bilang-Bleuel A; Revah F; Mallet J; Brundin P
Neuroscience; 1997 Jun; 78(3):703-13. PubMed ID: 9153652
[TBL] [Abstract][Full Text] [Related]
38. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
39. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
40. Morphological and functional evidence for enhanced growth and potassium-evoked dopamine release in striatal grafts innervated with a patchy growth pattern. An in oculo nigrostriatal cograft study.
Vidal N; Björklund L; Strömberg I
Cell Transplant; 1998; 7(2):97-108. PubMed ID: 9588592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
